← Bioventus Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | $86.8m | $43.9m | $31.8m | $37.0m | $41.6m | $51.2m | |
| Accounts receivable, net | $88.3m | $125.0m | $136.6m | $122.8m | $127.4m | $128.3m | |
| Inventory | $29.1m | $61.7m | $85.4m | $91.3m | $92.5m | $82.2m | |
| Prepaid and other current assets | $7.6m | $27.2m | $18.7m | $16.9m | $14.2m | $11.1m | |
| Total current assets | $211.8m | $263.1m | $272.6m | $268.0m | $275.6m | $272.8m | |
| Property and equipment, net | $6.9m | $23.0m | $27.6m | $36.6m | $27.0m | $21.9m | |
| Goodwill | $49.8m | $147.6m | $13.8m | $7.5m | $7.5m | $7.5m | |
| Intangible assets, net | $191.7m | $695.2m | $1.0b | $482.4m | $404.7m | $368.4m | |
| Investment and other assets | $19.4m | $29.3m | $2.6m | $3.1m | $1.9m | $2.3m | |
| Operating lease assets | $15.0m | $17.2m | $17.3m | $13.4m | $6.5m | $5.1m | |
| Deferred tax assets | $0 | $481k | $0 | $0 | $4.7m | $5.5m | |
| Current portion of contingent consideration | — | — | — | $0 | $19.6m | $0 | |
| Other current liabilities | $3.9m | $3.6m | $3.8m | $4.8m | $3.9m | $4.2m | |
| Total stockholders’ equity attributable to Bioventus Inc. | — | $458.9m | $316.6m | $173.6m | $147.9m | $184.1m | |
| Total stockholders’ equity | — | $533.8m | $340.3m | $221.1m | $185.6m | $228.4m | |
| Total assets | $494.5m | $1.2b | $1.4b | $810.9m | $728.0m | $683.6m | |
| Total liabilities and stockholders’ equity | $494.5m | $1.2b | $1.4b | $810.9m | $728.0m | $683.6m | |
| Accounts payable | $4.4m | $16.9m | $37.5m | $23.0m | $23.7m | $10.9m | |
| Accrued liabilities | $88.2m | $131.5m | $112.0m | $119.8m | $135.9m | $130.2m | |
| Current portion of long-term debt | $15.0m | $18.0m | $33.1m | $27.8m | $27.3m | $15.0m | |
| Long-term debt, less current portion | $173.4m | $339.6m | $385.0m | $367.0m | $308.3m | $279.0m | |
| Total current liabilities | $122.6m | $180.9m | $304.0m | $175.5m | $210.4m | $160.4m | |
| Deferred income tax liabilities | $3.4m | $133.5m | $154.0m | $1.2m | $564k | $433k | |
| Other long-term liabilities | $21.7m | $21.7m | $25.3m | $27.9m | $23.1m | $15.3m | |
| Total liabilities | $350.3m | $692.1m | $1.0b | $589.8m | $542.4m | $455.1m | |
| Common stock, value | — | $75k | $78k | $79k | $82k | $83k | |
| Additional paid-in capital | — | $465.3m | $481.9m | $494.3m | $505.5m | $520.9m | |
| Accumulated deficit | — | ($6.6m) | ($165.3m) | ($321.5m) | ($355.1m) | ($334.9m) | |
| Accumulated other comprehensive loss | — | $179k | ($110k) | $794k | ($2.6m) | ($1.9m) | |
| Noncontrolling interest | $0 | $74.9m | $23.8m | $47.5m | $37.7m | $44.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.